Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $133.13 Average Target Price from Analysts
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eighteen brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, fourteen have issued a buy rating and one has […]
29 Jun 10:03 · The Markets Daily